Healthcare Prime Radiant Partners Invests $50M in CellaresCellares provides automated clinical and commercial manufacturing services for cell and gene therapies. June 15, 2026
Healthcare Eli Lilly Buys Verve Therapeutics in $1.3B DealThe companies were already collaborating on one-time gene-editing treatments. June 17, 2025